Coronavirus: scientific and technological prospection of drugs in the study to treat Covid-19

Detalhes bibliográficos
Autor(a) principal: Oliveira, Elton Henrique Alves de
Data de Publicação: 2020
Tipo de documento: Artigo
Idioma: por
Título da fonte: Cadernos de Prospecção (Online)
Texto Completo: https://periodicos.ufba.br/index.php/nit/article/view/36153
Resumo: The world is facing a pandemic caused by a new disease known as Covid-19. This disease is a variation of the coronavirus family that causes respiratory infections. Fiocruz will coordinate, in Brazil, the clinical trial Solidarity (Solidarity), of the World Health Organization (WHO), which aims to develop some medication for the new coronavirus. Considering the action of Fiocruz, the objective of this article is to map the drugs in phases of clinical tests that will be used in the actions of the project to combat Covid-19. Three article bases were chosen, Scielo, Pubmed and Capes, and three patent bases, which were INPI, USPTO and ESPACENET. The results obtained were analyzed quantitatively for where it concludes positive future perspectives on the technological development for the treatment of the new coronavirus, where of the 25,922 results found, 6,914 articles correspond to 27% and patents correspond to 73% of searches, which is equivalent to the 19,008 cases found.
id UFBA-6_3a8bdaf01b20f88d71099d9df67a45dc
oai_identifier_str oai:ojs.periodicos.ufba.br:article/36153
network_acronym_str UFBA-6
network_name_str Cadernos de Prospecção (Online)
repository_id_str
spelling Coronavirus: scientific and technological prospection of drugs in the study to treat Covid-19Coronavírus: prospecção científica e tecnológica dos fármacos em estudo para tratamento da Covid-19Covid-19ProspecçãoFármaco.Covid-19ProspectionPharmaceutical.The world is facing a pandemic caused by a new disease known as Covid-19. This disease is a variation of the coronavirus family that causes respiratory infections. Fiocruz will coordinate, in Brazil, the clinical trial Solidarity (Solidarity), of the World Health Organization (WHO), which aims to develop some medication for the new coronavirus. Considering the action of Fiocruz, the objective of this article is to map the drugs in phases of clinical tests that will be used in the actions of the project to combat Covid-19. Three article bases were chosen, Scielo, Pubmed and Capes, and three patent bases, which were INPI, USPTO and ESPACENET. The results obtained were analyzed quantitatively for where it concludes positive future perspectives on the technological development for the treatment of the new coronavirus, where of the 25,922 results found, 6,914 articles correspond to 27% and patents correspond to 73% of searches, which is equivalent to the 19,008 cases found.O mundo está enfrentando uma pandemia causada por uma nova doença conhecida como Covid-19. Essa doença é uma variação da família do Coronavírus que causa infecções respiratórias. A Fiocruz coordenará, no Brasil, o ensaio clínico Solidariedade (Solidarity), da Organização Mundial da Saúde (OMS), que tem como intuito desenvolver algum medicamento para o combate ao novo Coronavírus. Considerando a ação da Fiocruz, o objetivo deste artigo é mapear os fármacos em fases de testes clínicos que serão utilizados nas ações do projeto de combate à Covid-19. Foram escolhidas três bases de artigos, Scielo, Pubmed e Capes, e três bases de patentes, INPI, USPTO e ESPACENET. Os resultados obtidos foram analisados quantitativamente para se concluir que há perspectivas futuras positivas sobre o desenvolvimento tecnológico para tratamento do novo Coronavírus. Dos 25.922 resultados encontrados, 6.914 artigos correspondem a 27%, e as patentes correspondem a 73% das buscas, o que equivale a 19.008 processos encontrados.Universidade Federal da Bahia2020-04-16info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionProspecçãoapplication/pdfhttps://periodicos.ufba.br/index.php/nit/article/view/3615310.9771/cp.v13i2.36153Cadernos de Prospecção; Vol. 13 No. 2 (2020): Edição Especial - Coronavírus (SARS-COV-2) e COVID-19; 412Cadernos de Prospecção; v. 13 n. 2 (2020): Edição Especial - Coronavírus (SARS-COV-2) e COVID-19; 4122317-00261983-1358reponame:Cadernos de Prospecção (Online)instname:Universidade Federal da Bahia (UFBA)instacron:UFBAporhttps://periodicos.ufba.br/index.php/nit/article/view/36153/20963Copyright (c) 2020 Cadernos de Prospecçãohttps://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessOliveira, Elton Henrique Alves de2022-03-03T11:41:27Zoai:ojs.periodicos.ufba.br:article/36153Revistahttps://periodicos.ufba.br/index.php/nitPUBhttps://periodicos.ufba.br/index.php/nit/oaicadernosdeprospeccao@gmail.com || maliceribeiro@yahoo.com.br || cadernosdeprospeccao@gmail.com || saionaraluna@gmail.com2317-00261983-1358opendoar:2022-03-03T11:41:27Cadernos de Prospecção (Online) - Universidade Federal da Bahia (UFBA)false
dc.title.none.fl_str_mv Coronavirus: scientific and technological prospection of drugs in the study to treat Covid-19
Coronavírus: prospecção científica e tecnológica dos fármacos em estudo para tratamento da Covid-19
title Coronavirus: scientific and technological prospection of drugs in the study to treat Covid-19
spellingShingle Coronavirus: scientific and technological prospection of drugs in the study to treat Covid-19
Oliveira, Elton Henrique Alves de
Covid-19
Prospecção
Fármaco.
Covid-19
Prospection
Pharmaceutical.
title_short Coronavirus: scientific and technological prospection of drugs in the study to treat Covid-19
title_full Coronavirus: scientific and technological prospection of drugs in the study to treat Covid-19
title_fullStr Coronavirus: scientific and technological prospection of drugs in the study to treat Covid-19
title_full_unstemmed Coronavirus: scientific and technological prospection of drugs in the study to treat Covid-19
title_sort Coronavirus: scientific and technological prospection of drugs in the study to treat Covid-19
author Oliveira, Elton Henrique Alves de
author_facet Oliveira, Elton Henrique Alves de
author_role author
dc.contributor.author.fl_str_mv Oliveira, Elton Henrique Alves de
dc.subject.por.fl_str_mv Covid-19
Prospecção
Fármaco.
Covid-19
Prospection
Pharmaceutical.
topic Covid-19
Prospecção
Fármaco.
Covid-19
Prospection
Pharmaceutical.
description The world is facing a pandemic caused by a new disease known as Covid-19. This disease is a variation of the coronavirus family that causes respiratory infections. Fiocruz will coordinate, in Brazil, the clinical trial Solidarity (Solidarity), of the World Health Organization (WHO), which aims to develop some medication for the new coronavirus. Considering the action of Fiocruz, the objective of this article is to map the drugs in phases of clinical tests that will be used in the actions of the project to combat Covid-19. Three article bases were chosen, Scielo, Pubmed and Capes, and three patent bases, which were INPI, USPTO and ESPACENET. The results obtained were analyzed quantitatively for where it concludes positive future perspectives on the technological development for the treatment of the new coronavirus, where of the 25,922 results found, 6,914 articles correspond to 27% and patents correspond to 73% of searches, which is equivalent to the 19,008 cases found.
publishDate 2020
dc.date.none.fl_str_mv 2020-04-16
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Prospecção
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://periodicos.ufba.br/index.php/nit/article/view/36153
10.9771/cp.v13i2.36153
url https://periodicos.ufba.br/index.php/nit/article/view/36153
identifier_str_mv 10.9771/cp.v13i2.36153
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://periodicos.ufba.br/index.php/nit/article/view/36153/20963
dc.rights.driver.fl_str_mv Copyright (c) 2020 Cadernos de Prospecção
https://creativecommons.org/licenses/by-nc/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Cadernos de Prospecção
https://creativecommons.org/licenses/by-nc/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal da Bahia
publisher.none.fl_str_mv Universidade Federal da Bahia
dc.source.none.fl_str_mv Cadernos de Prospecção; Vol. 13 No. 2 (2020): Edição Especial - Coronavírus (SARS-COV-2) e COVID-19; 412
Cadernos de Prospecção; v. 13 n. 2 (2020): Edição Especial - Coronavírus (SARS-COV-2) e COVID-19; 412
2317-0026
1983-1358
reponame:Cadernos de Prospecção (Online)
instname:Universidade Federal da Bahia (UFBA)
instacron:UFBA
instname_str Universidade Federal da Bahia (UFBA)
instacron_str UFBA
institution UFBA
reponame_str Cadernos de Prospecção (Online)
collection Cadernos de Prospecção (Online)
repository.name.fl_str_mv Cadernos de Prospecção (Online) - Universidade Federal da Bahia (UFBA)
repository.mail.fl_str_mv cadernosdeprospeccao@gmail.com || maliceribeiro@yahoo.com.br || cadernosdeprospeccao@gmail.com || saionaraluna@gmail.com
_version_ 1799319847814823936

Registros relacionados